• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2013 Fiscal Year Final Research Report

Proteomic and metabolomic analysis on chemo-sensitivity and resistance of cancer towards personalized medicine

Research Project

  • PDF
Project/Area Number 23390037
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Medical pharmacy
Research InstitutionKeio University

Principal Investigator

TANIGAWARA Yusuke  慶應義塾大学, 医学部, 教授 (30179832)

Co-Investigator(Kenkyū-buntansha) NISHI Koji  慶應義塾大学, 医学部, 特任講師 (00398249)
NISHIMUTA Akito  慶應義塾大学, 医学部, 特任助教 (00424135)
Project Period (FY) 2011-04-01 – 2014-03-31
Keywords抗がん剤 / 薬剤反応性 / プロテオーム / メタボローム / オーダーメイド医療
Research Abstract

Inter-patient variability in the efficacy of cancer pharmacotherapy is one of the most difficult obstacles to improve cancer therapy. The present research investigated cellular mechanisms of pharmacological action of chemotherapeutic agents and resistant mechanisms of cancer against the drug action. The methods we used were the latest proteomic and metabolomic analyses which measured intracellular expression of abundant proteins and metabolites. Based on comprehensive metabolomic fingerprints and protein expression analysis, we have discovered several new proteins and metabolites that are related to the chemo-sensitivity or drug resistance of cancer. These findings are expected to lead to develop a new personalized cancer pharmacotherapy.

  • Research Products

    (27 results)

All 2014 2013 2012 2011

All Journal Article (7 results) (of which Peer Reviewed: 7 results) Presentation (13 results) (of which Invited: 4 results) Book (1 results) Patent(Industrial Property Rights) (6 results) (of which Overseas: 3 results)

  • [Journal Article] Forced expression of S100A10 reduces sensitivity to oxaliplatin in colorectal cancer cells2014

    • Author(s)
      Suzuki S, Tanigawara Y
    • Journal Title

      Proteome Science

      Volume: 12 Pages: 26

    • DOI

      10.1186/1477-5956-12-26

    • Peer Reviewed
  • [Journal Article] Polymorphisms in the UGT1A1 gene predict adverse effects of irinotecan in the treatment of gynecologic cancer in Japanese patients2013

    • Author(s)
      Hirasawa A, Zama T, Akahane T, Nomura H, Kataoka F, Saito K, Okubo K, Tominaga E, Makita K, Susumu N, Kosaki K, Tanigawara Y, Aoki D
    • Journal Title

      J Hum Genet

      Volume: 58(12) Pages: 794-8

    • DOI

      10.1038/jhg.2013.105

    • Peer Reviewed
  • [Journal Article] Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients2013

    • Author(s)
      Kim HR, Park HS, Kwon WS, Lee JH, Tanigawara Y, Lim SM, Kim HS, Shin SJ, Ahn JB, Rha SY
    • Journal Title

      Cancer Chemother Pharmacol

      Volume: 72(4) Pages: 825-35

    • DOI

      10.1007/s00280-013-2258-y

    • Peer Reviewed
  • [Journal Article] A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese2012

    • Author(s)
      Kiyotani K, Mushiroda T, Tsunoda T, Morizono T, Hosono N, Kubo M, Tanigawara Y, Imamura CK, Flockhart DA, Aki F, Hirata K, Takatsuka Y, Okazaki M, Ohsumi S, Yamakawa T, Sasa M, Nakamura Y, Zembutsu H
    • Journal Title

      Hum Mol Genet

      Volume: 21(7) Pages: 1665-72

    • DOI

      10.1093/hmg/ddr597

    • Peer Reviewed
  • [Journal Article] Dose-adjustment study of tamoxifen based on CYP2D6 genotypes in Japanese breast cancer patients2012

    • Author(s)
      Kiyotani K, Mushiroda T, Imamura CK, Tanigawara Y, Hosono N, Kubo M, Sasa M, Nakamura Y, Zembutsu H
    • Journal Title

      Breast Cancer Res Treat

      Volume: 131(1) Pages: 137-45

    • DOI

      10.1007/s10549-011-1777-7

    • Peer Reviewed
  • [Journal Article] Blood-direct InvaderPlus as a new method for genetic testing2012

    • Author(s)
      Hirasawa A, Akahane T, Tanigawara Y, Aoki D
    • Journal Title

      Personalized Medicine

      Volume: 9 Pages: 657-663

    • DOI

      10.2217/pme.12.71

    • Peer Reviewed
  • [Journal Article] S100A10 protein expression is associated with oxaliplatin sensitivity in human colorectal cancer cells2011

    • Author(s)
      Suzuki S, Yamayoshi Y, Nishimuta A, Tanigawara Y
    • Journal Title

      Proteome Science

      Volume: 9 Pages: 76

    • DOI

      10.1186/1477-5956-9-76

    • Peer Reviewed
  • [Presentation] Pharmacogenomics-based personalized dosing of tamoxifen : Solution for controversy2013

    • Author(s)
      Tanigawara Y
    • Organizer
      第72回日本癌学会学術総会
    • Place of Presentation
      横浜
    • Year and Date
      2013-10-04
    • Invited
  • [Presentation] ヒト大腸がん細胞における5-FU 耐性のメタボローム解析2013

    • Author(s)
      藤原裕, 西牟田章戸, 川島知憲, 谷川原祐介
    • Organizer
      第72回日本癌学会学術総会
    • Place of Presentation
      横浜
    • Year and Date
      2013-10-03
  • [Presentation] ヒト膵臓細胞におけるゲムシタビン耐性のメタボローム解析2013

    • Author(s)
      森本洋輔, 西 弘二, 川島知憲, 谷川原祐介
    • Organizer
      第72回日本癌学会学術総会
    • Place of Presentation
      横浜
    • Year and Date
      2013-10-03
  • [Presentation] Cancer biomarkers in diagnostics and pharmacotherapy2013

    • Author(s)
      Tanigawara Y
    • Organizer
      FIP (International Pharmaceutical Federation)
    • Place of Presentation
      Dublin, Ireland
    • Year and Date
      2013-09-03
    • Invited
  • [Presentation] がん薬物療法の個別化に向けたPK/PD と統合オミックス研究2013

    • Author(s)
      谷川原祐介
    • Organizer
      第50回薬剤学懇談会研究討論会
    • Place of Presentation
      札幌
    • Year and Date
      2013-06-26
  • [Presentation] TDM のサイエンスとプラクティス2013

    • Author(s)
      谷川原祐介
    • Organizer
      第30回日本TDM 学会・学術大会
    • Place of Presentation
      熊本
    • Year and Date
      2013-05-26
  • [Presentation] メタボローム解析によるヒト大腸癌細胞の5-FU+オキサリプラチンに対する応答機構の解明2012

    • Author(s)
      津崎盾哉, 西牟田章戸, 谷川原祐介
    • Organizer
      第10回日本臨床腫瘍学会学術集会
    • Place of Presentation
      大阪
    • Year and Date
      2012-07-27
  • [Presentation] Pharmaco-metabolomics for anticancer drugs2012

    • Author(s)
      Tanigawara Y
    • Organizer
      第10回日本臨床腫瘍学会学術集会
    • Place of Presentation
      大阪
    • Year and Date
      2012-07-26
  • [Presentation] Pharmaco-metabolomics of anticancer drugs2012

    • Author(s)
      Tanigawara Y
    • Organizer
      10th International Conference of the Asian Clinical Oncology Society
    • Place of Presentation
      Seoul, Korea
    • Year and Date
      2012-06-14
  • [Presentation] Pharmacogenomics2011

    • Author(s)
      Tanigawara Y
    • Organizer
      第49回日本癌治療学会学術集会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-11-28
    • Invited
  • [Presentation] Post-genome proteomic and metabolomic analyses for pharmacological responses to anticancer agents2011

    • Author(s)
      Tanigawara Y
    • Organizer
      第49回日本癌治療学会学術集会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-11-27
    • Invited
  • [Presentation] Cancer metabolomics by MS technology2011

    • Author(s)
      Tanigawara Y
    • Organizer
      12th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (Plenary Lecture)
    • Place of Presentation
      Stuttgart, Germany
    • Year and Date
      2011-11-06
  • [Presentation] メタボローム解析による大腸癌細胞のオキサリプラチン感受性因子の探索2011

    • Author(s)
      大谷勇紀, 西牟田章戸, 谷川原祐介
    • Organizer
      第9回日本臨床腫瘍学会学術集会
    • Place of Presentation
      横浜
    • Year and Date
      2011-07-21
  • [Book] 薬物動態・薬力学から見たがん個別化治療の現状と展望2014

    • Author(s)
      谷川原祐介
    • Total Pages
      678-684
    • Publisher
      日本臨床社
  • [Patent(Industrial Property Rights)] 抗がん剤感受性判定マーカー2014

    • Inventor(s)
      谷川原祐介, 渡辺光博, 有田恵理, 西牟田章戸, 山吉康子, 松崎 健, 杉本伸二
    • Industrial Property Rights Holder
      学校法人慶應義塾, 株式会社ヤクルト本社
    • Industrial Property Rights Type
      特許(欧州)
    • Industrial Property Number
      European patent No. 2237042
    • Acquisition Date
      2014-03-12
    • Overseas
  • [Patent(Industrial Property Rights)] 抗がん剤感受性判定マーカー2014

    • Inventor(s)
      谷川原祐介, 渡辺光博, 有田恵理, 西牟田章戸, 山吉康子, 松崎 健, 杉本伸二
    • Industrial Property Rights Holder
      学校法人慶應義塾, 株式会社ヤクルト本社
    • Industrial Property Rights Type
      特許(日本国)
    • Industrial Property Number
      特許第5461200号
    • Acquisition Date
      2014-01-24
  • [Patent(Industrial Property Rights)] 抗がん剤感受性の判定方法2014

    • Inventor(s)
      谷川原祐介, 鈴木小夜, 杉本伸二
    • Industrial Property Rights Holder
      学校法人慶應義塾, 株式会社ヤクルト本社
    • Industrial Property Rights Type
      特許(日本国)
    • Industrial Property Number
      特許第5461201号
    • Acquisition Date
      2014-01-24
  • [Patent(Industrial Property Rights)] 抗がん剤感受性の判定マーカー2012

    • Inventor(s)
      谷川原祐介, 西牟田章戸, 大谷勇紀, 松尾光寿
    • Industrial Property Rights Holder
      学校法人慶應義塾, 株式会社ヤクルト本社
    • Industrial Property Rights Type
      特許(PCT)
    • Industrial Property Number
      PCT/JP2012/54633
    • Filing Date
      2012-03-24
    • Overseas
  • [Patent(Industrial Property Rights)] 併用抗がん剤の感受性判定マーカー2012

    • Inventor(s)
      谷川原祐介, 西牟田章戸, 津崎盾哉, 高橋寛行
    • Industrial Property Rights Holder
      学校法人慶應義塾, 株式会社ヤクルト本社
    • Industrial Property Rights Type
      特許(日本国)
    • Industrial Property Number
      特願2012-37448
    • Filing Date
      2012-02-23
  • [Patent(Industrial Property Rights)] 抗がん剤の感受性の判定方法2012

    • Inventor(s)
      谷川原祐介, 西牟田章戸, 鈴木小夜, 鈴木哲也, 生駒祐介, 杉本伸二
    • Industrial Property Rights Holder
      学校法人慶應義塾, 株式会社ヤクルト本社
    • Industrial Property Rights Type
      特許(米国)
    • Industrial Property Number
      US patent 13/504985
    • Acquisition Date
      2012-03-24
    • Overseas

URL: 

Published: 2015-06-25  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi